Subsequently, we have presented a novel strategy to improve RGD4C-AAVP gene transfer to melanoma, specifically and other cancers that express HDAC6, by combining RGD4C-AAVP with selective inhibition of HDAC6 by using the C1A inhibitor. This evidence concerns the gene HDAC6 and melanoma.